前体药物的合成 Synthesis of prodrugs
前体药物制剂 pro-drug preparations
前体药物疗法 Antibody directed enzyme prodrug therapy ; ADEPT
前体药物治疗 GDEPT ; VDEPT ; virus-directed enzyme/prodrug therapy
前体药物的分解 Synthesis of prodrugs
生物前体药物 bioprecursors prodrugs
酶前体药物治疗 Antibody-directed enzyme prodrug therapy ; ADEPT
酶前体药物疗法 gene directed enzyme prodrug therapy
酶一前体药物疗法 antibody-directed enzyme prodrug therapy ; ADEPT
只有病人的多巴胺生成细胞能够摄取前体药物分子并转化为多巴胺，病人的症状才能缓解。
The symptoms can only be relieved if the patient's dopamine-producing cells are capable of taking up the precursor molecules and converting them into dopamine.
随着病程进展，病人细胞转化前体药物的能力也越来越弱。
The further the disease progresses, the weaker the capacity of the patient's cells to convert the precursor drug.
目的制备盐酸他克林(THA)的酰化前体药物以提高其透过血脑屏障(BBB)的能力。
Aim to synthesize acylated prodrug of tacrine hydrochloride (THA) to improve the infiltration ability across the blood brain barrier (BBB).
应用推荐